Literature DB >> 28212493

Detecting and Managing Neuropsychiatric Symptoms in Dementia.

Andrea Iaboni1,2, Mark J Rapoport2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28212493      PMCID: PMC5317019          DOI: 10.1177/0706743716672409

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  20 in total

Review 1.  Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review.

Authors:  Dallas P Seitz; Sarah Brisbin; Nathan Herrmann; Mark J Rapoport; Kimberley Wilson; Sudeep S Gill; Jenna Rines; Ken Le Clair; David Conn
Journal:  J Am Med Dir Assoc       Date:  2012-02-17       Impact factor: 4.669

2.  Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.

Authors:  Meryl A Butters; Rishi K Bhalla; Carmen Andreescu; Julie Loebach Wetherell; Rose Mantella; Amy E Begley; Eric J Lenze
Journal:  Br J Psychiatry       Date:  2011-07-04       Impact factor: 9.319

3.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study.

Authors:  Andrea Iaboni; Susan E Bronskill; Katelyn B Reynolds; Xuesong Wang; Paula A Rochon; Nathan Herrmann; Alastair J Flint
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

5.  Choosing Wisely: Wise Choices in Psychiatry.

Authors:  Douglas Urness; Naomi J Parker; Mark J Rapoport; Thomas C R Wilkes
Journal:  Can J Psychiatry       Date:  2016-04-06       Impact factor: 4.356

Review 6.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

7.  Impact of FDA Black Box Warning on Psychotropic Drug Use in Noninstitutionalized Elderly Patients Diagnosed With Dementia: A Retrospective Study.

Authors:  Rakesh R Singh; Rajesh Nayak
Journal:  J Pharm Pract       Date:  2015-04-27

8.  Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.

Authors:  Elmira Valiyeva; Nathan Herrmann; Paula A Rochon; Sudeep S Gill; Geoffrey M Anderson
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

9.  Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort Study.

Authors:  Gavin Mast; Kimberly Fernandes; Mina Tadrous; Diana Martins; Nathan Herrmann; Tara Gomes
Journal:  Drugs Real World Outcomes       Date:  2016-05-13

10.  Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).

Authors:  Serge Gauthier; Christopher Patterson; Howard Chertkow; Michael Gordon; Nathan Herrmann; Kenneth Rockwood; Pedro Rosa-Neto; Jean-Paul Soucy
Journal:  Can Geriatr J       Date:  2012-12-04
View more
  1 in total

1.  Measuring neuropsychiatric symptoms in patients with early cognitive decline using speech analysis.

Authors:  Alexandra König; Elisa Mallick; Johannes Tröger; Nicklas Linz; Radia Zeghari; Valeria Manera; Philippe Robert
Journal:  Eur Psychiatry       Date:  2021-10-13       Impact factor: 5.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.